XJ-PLT-001

N/A

Report date: 2025/05/16 15:01:18

Base Information

Drug NameXJ-PLT-001
Drug Alias NameXJ-PLT-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBernard-Soulier Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Xueji Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Xueji Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsBernard-Soulier Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A